Thank you to our speakers, sponsors, and delegates who joined us in March for the summit!
If you are interested in the 2025 event, please get in touch at info@hansonwade.com
Overcoming Regulatory & Operational Hurdles to Provide Patients with Access to Life Changing Therapeutics
Welcome to the 4th Operationalize Expanded Access Programs Summit
With the increasing interest in access to investigational medicines from patients, the harmonization of guidance and research on the value of expanded access programs witnessed a critical rise.
This event was the only industry forum defining global regulations for EAP and was a definitive networking opportunity to connect with managed access teams from other leading and new companies that were immersing themselves in this evolving field of opportunity and life-changing support.
120+ industry experts reunited, setting up and leading EAPs at the 4th Operationalize Expanded Access Programs Summit. Attendees gained practical take aways on how to construct a reliable system, define a clear exit strategy, understand updated local and global regulations, and determine the role of real-world data to optimize the operationalization of your EAP.
This was your opportunity to be amongst physicians, patients and passionate EAP and clinical supply experts from Novartis, Daiichi Sankyo, GSK, AstraZeneca, Gilead, Biogen, Sanofi, Eli Lilly, Regeneron, and many more to discover novel strategies in overcoming operational hurdles and deliver life-saving treatments to patients more efficiently.
World-Class Speaker Faculty Included:
Elif Oral
Professor - Department of Internal Medicine, Division of Metabolism Endocrinology and Diabetes (MEND)
University of Michigan Health System
Companies Attended Included:
2024 Speaker Highlights:
Ramona Reichenbach, Head of Managed Access Center of Excellence at Novartis and Elif Oral, Professor at the University of Michigan as they delve into physicians’ pain points, real world data collection and patient consent and assent
Irfan Mohammed, Director, Chemistry, Manufacturing & Controls Team Lead Product Development & Clinical Supply at Alexion, AstraZeneca Rare to ensure labelling consistency and compliance across the supply chain and review multinational labelling requirements
Katie Bowen, Expanded Access Coordinator at GSK to highlight practical strategies and important factors to consider to successfully deliver a project in the Middle East
Jasmina Ahrens, Expanded Access Coordinator at GSK to highlight practical strategies and important factors to consider to successfully deliver a project in the Middle East
Our 2024 Partners:
Other Events in the Series:
